One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi

In Malawi, 236 participants from the Advancing Cryptococcal Meningitis Treatment for Africa trial were followed for 12 months. The trial outcomes reported at 10 weeks were sustained to 1 year. One-week amphotericin B plus flucytosine was associated with the lowest 1 year mortality (27.5% [95% confid...

Full description

Saved in:
Bibliographic Details
Published in:Clin Infect Dis
Main Authors: Kanyama, Cecilia, Molloy, Síle F, Chan, Adrienne K, Lupiya, Duncan, Chawinga, Chimwemwe, Adams, Jack, Bright, Philip, Lalloo, David G, Heyderman, Robert S, Lortholary, Olivier, Jaffar, Shabbar, Loyse, Angela, van Oosterhout, Joep J, Hosseinipour, Mina C, Harrison, Thomas S
Format: Artigo
Language:Inglês
Published: Oxford University Press 2020
Subjects:
Brief Reports
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7105249/
https://ncbi.nlm.nih.gov/pubmed/31155650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciz454
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items